MedTrace Logo

Nucleus Hybrid L24 Extended Duration Post Approval Study

NCT02379273 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-11-30

Study results available
· View outcomes & findings →

Summary

This post approval study evaluates the long term safety and efficacy of the Nucleus Hybrid L24 Implant System in a group of already implanted recipients.

Conditions

Interventions

DEVICE

Nucleus Hybrid L24 Implant

Subjects have already been implanted with the Nucleus Hybrid L24 implant.

Sponsors & Collaborators

  • University of Iowa

    collaborator OTHER

  • NYU Langone Health

    collaborator OTHER

  • Midwest Ear Institute

    collaborator OTHER

  • University of Cincinnati

    collaborator OTHER

  • The Center for Hearing and Balance Disorders

    collaborator AMBIG

  • Ohio State University

    collaborator OTHER

  • Mayo Clinic

    collaborator OTHER

  • Hearts for Hearing

    collaborator OTHER

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Bruce J Gantz, MD · University of Iowa

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-14
Primary Completion
2019-03-18
Completion
2019-03-18

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02379273 on ClinicalTrials.gov